Analyst Profile

Followed by 550 followers
.
Robert Hazlett

Robert Hazlett

BTIG
Wall Street Analyst
#2,690 out of 8,166 Wall Street Analysts
#6,045 out of 24,458 experts

Success Rate

37%
66 out of 177 transactions made a profit

Average Return

+3.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Robert Hazlett's trades since 2009 and holding each position for 1 Year would result in 37.29% of your transactions generating a profit, with an average return of 3.7% per rating.

Stock Rating Distribution

211Ratings
92.42% Buy
7.11% Hold
0.47% Sell
Distribution of Robert Hazlett's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Axsome Therapeutics Inc.
(AXSM)
Rating:Buy
Date:Jan 08, 2019 - Jan 08, 2020
Return:+800.00%
The most profitable rating made by Robert Hazlett

Robert Hazlett's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Merck & Company
Nov 16, 2009
Buy
Reiterated
1Ratings
100%
+5.10%
VVUSQ
Vivus
Nov 06, 2012
Hold
Reiterated
1Ratings
0.00%
Rigel
Jun 04, 2013
Hold
Downgraded
1Ratings
0.00%
ECYT
Endocyte
Aug 01, 2013
Buy
Assigned
1Ratings
0%
-66.10%
ImmunoGen
Aug 26, 2013
Buy
Initiated
$19.00
(254.48% Upside)
1Ratings
0%
-26.00%
Neurocrine
Sep 09, 2013
Buy
Assigned
$16.00
(-87.11% Downside)
2Ratings
50%
+1.80%
Amarin
Oct 16, 2013
Buy
Assigned
$5.00
(331.03% Upside)
1Ratings
0%
-79.60%
Xoma
Oct 31, 2013
Buy
Assigned
$8.00
(-59.35% Downside)
1Ratings
0%
-4.80%
ARLZQ
Aralez Pharmaceuticals
Nov 19, 2013
Buy
Assigned
1Ratings
100%
+60.90%
Acura Pharmaceuticals
May 22, 2014
Buy
Initiated
$2.50
(4900.00% Upside)
2Ratings
0%
-42.10%
List of latest recommendations made by Robert Hazlett. Click to expand and see Robert Hazlett's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >